Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Guaranteed Paid Placement
    • Cision Media Monitoring
    • Multichannel Amplification
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Multichannel Amplification
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Cision IR
  • SocialBoost
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

"Transfersome Gel" a New Solution for Hypertrophic Scars Chula Pharmacy's Latest Innovation


News provided by

Chulalongkorn University

16 Sep, 2024, 10:00 CST

Share this article

Share toX

Share this article

Share toX

BANGKOK, Sept. 16, 2024 /PRNewswire/ -- Lecturers at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, have developed an alternative "Transfersome Gel" to help treat hypertrophic scars and dark marks. This gel, made from a key substance found in the Indian pennywort (Centella asiatica) plant, features a special technique that has earned it the International Gold Medal of Innovation at ITEX 2024 and a special award from the Korea Invention Promotion Association. 

Continue Reading

"Scars" are something most people want to avoid because they can be difficult or even impossible to completely heal, sometimes lasting for life. This is especially true for hypertrophic scars, which are prominent, visible scars like those on the face, as they can significantly impact one's confidence. People with scars often seek ways to eliminate them. Nowadays, there are several treatment options for hypertrophic scars, including surgery, steroid injections, laser therapy, and topical products.

"Steroid injections can thin the skin, and lasers can be painful. Most scar removal products are imported from abroad and can be expensive," says Assistant Professor Dr. Romchat Chutoprapat, Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Science, Chulalongkorn University. She discusses the challenges of scar treatment that have led to the research and innovation of "Asiatic acid-loaded transfersome gel" under the auspices of the National Research Council of Thailand (NRCT).

"Based on the problem, we researched Thai herbs that can address hypertrophic scars and found that the "Asiatic Acid" in Indian pennywort (Centella asiatica) has a strong anti-inflammatory effect on the skin. However, it cannot be applied directly to the scars. Therefore, we have developed a method to maximize its effectiveness by encapsulating the essence in transfersome vesicles within a gel. This approach allows the essence to adhere to and penetrate the skin more effectively."

The innovation "Asiatic acid-loaded transfersome gel" received the Gold Medal and the Special Prize for the Best International Invention from the Korea Invention Promotion Association at the Invention, Innovation and Technology Exhibition 2024 (ITEX 2024) in Kuala Lumpur, Malaysia, on May 17, 2024.

What is a Transfersome?

Asst. Prof. Dr. Romchat explained that the "Asiatic Acid" from the Indian pennywort (Centella asiatica) has anti-inflammatory effects on the skin, disinfects, and promotes wound heal, but it is water-insoluble. When applied directly to the skin, the substance cannot penetrate the inflamed skin layer. Therefore, it is necessary to use a substance-delivery technology known as Transfersome.

"Transfersome is a drug delivery technology that encapsulates active ingredients in nanovesicles with excellent elasticity, allowing for effective delivery of essential substances into the skin. Additionally, the research team has developed the product in gel form, which has a film-like appearance that adheres well to the scar area for an extended period, thus enhancing absorption around the scar."

What causes hypertrophic scars?

Asst. Prof. Dr. Romchat explained the body's process for dealing with and healing wounds in three steps:

Step 1: When a wound occurs, the body first stops the bleeding, and initiates inflammation to destroy pathogens and remove dead tissue.

Step 2: The body generates new tissue to replace the dead tissue.

Step 3: The body then attempts to reshape the wound to closely resemble the original skin.

"If the wound healing process in Step 2 is abnormal due to prolonged, chronic, or severe inflammation, the body may not heal properly. This can affect Step 3, leading to misshapen scars. The body may continue to build excessive tissue, resulting in hypertrophic scars or keloids," explained Asst. Prof. Dr. Romchat.

How does Transfersome Gel heal hypertrophic scars?

Chronic inflammation is a major contributor to hypertrophic scars. By suppressing excessive inflammation, it is possible to reduce the appearance of raised scar.

The "Asiatic acid-loaded transfersomes" in a gel have anti-inflammatory effects, which significantly reduces the likelihood of raised scars. When the product is used consistently, morning and evening, noticeable results can often be seen within the first 2 weeks. The body will work to reshape the bulging area to more closely resemble the original skin," said Asst. Prof. Dr. Romchat, who recommends starting to use the product 3 days after the wound occurs, or when the wound has completely dried out.

In addition to addressing bulging scars, "Asiatic acid-loaded transfersome gel" can also be used for dark blemishes from acne scars or from scratching or picking at scabs.

"Raised scars can make us feel tight and itchy around the scar area. The skin in that area may become much drier and may develop dark or red marks. Using Asiatic acid-loaded transfersome gel can restore suppleness to the skin, as well as reduce pigmentation in the scar area, helping diminish dark spots," explained Asst. Prof. Dr. Romchat.

Asst. Prof. Dr. Romchat said that the Asiatic acid-loaded transfersome gel is most effective when applied to scars that are less than one year old.  While it is still beneficial for older scars, it may take a longer time for the product to show results.

"We can continue to use this gel until the desired results are achieved without any harm, as the transfersome gel contains substances listed in the CosIng EU database as 'safe for use on the skin.', It can even be used safely by people with sensitive skin," assured Asst. Prof. Dr. Romchat.

Transfersome, a value-added innovation for beauty care and anti-aging products

Transfersome is a substance delivery technology that can be used for delivering various compounds, including Asiatic acid found in Indian pennywort.

"With Transfersome gel's ability to reduce dark spots and increase skin elasticity, we can also adapt the formulation for anti-aging applications," said Asst. Prof. Dr. Romchat, referring to the future development and use of transfersome technology in the pharmaceutical and cosmetic manufacturing industries.

The innovation "Asiatic acid-loaded transfersome gel" is a product of the start-up Beauty Plant Laboratory Co., Ltd., incubated by the Faculty of Pharmaceutical Sciences, Chulalongkorn University, and CU Innovation Hub. The technology has now been applied for patent by the Intellectual Property Institute of Chulalongkorn University and is being prepared for registration as a cosmetic product, with the aim of eventually registering it as a medical device in the future. Interested parties wishing to explore business partnerships may contact us at: [email protected].

 For the full release and more images, please visit: https://www.chula.ac.th/en/highlight/184395/ 

About Chulalongkorn University

Chulalongkorn University has made the world's top 50 university list for employment outcomes, which reflects both the high employment rate and workability of Chula graduates. The university is also listed as the best in Thailand for the 15th Consecutive Year (since 2009), according to the newly released QS World University Rankings 2024, putting Chula at 211th in the world, up from 244th last year.

Social Media:

Facebook: https://www.facebook.com/ChulalongkornUniversity
Youtube: https://www.youtube.com/chulauniversity
Linkedin: https://www.linkedin.com/school/15101896/

SOURCE Chulalongkorn University

Modal title

Also from this source

Chulalongkorn University's Faculty of Arts Offering "Dracula and Modern Culture": From Horror Literature to a Reflection of Contemporary Culture

Chulalongkorn University's Faculty of Arts Offering "Dracula and Modern Culture": From Horror Literature to a Reflection of Contemporary Culture

In today's digital age, where knowledge is simply accessible at one's fingertips, Chulalongkorn University, as a leading educational institution in...

Gender Inequality: The Global Challenge of Making Their Voices Heard

Across the Asia-Pacific, millions of girls face barriers that limit their potential — and change cannot wait. Dr. Christina Warning, a distinguished...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Cosmetics and Personal Care

Cosmetics and Personal Care

Education

Education

News Releases in Similar Topics

Contact Cision

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2025 Cision US Inc.